Wheat

Wheat (Triticum aestivum L.): A Comprehensive Reference

1. Identity: Botanical Classification, Species, and Common Forms

1.1 Taxonomy and Botanical Names

All wheats belong to the Triticum genus within the large Poaceae family. The main wheat species cultivated are Triticum aestivum L., the "common" or "bread" wheat, and Triticum turgidum ssp. durum, which is used for making pasta, referred to as "durum wheat." Other species of the Triticum genus that significantly contributed to human diet for millennia are nowadays very marginally grown and used.

Common wheat (Triticum aestivum), one of the world's most consumed cereal grains, is known for its uses in baking and cooking in addition to its medicinal uses. The genus name Triticum is derived from the Latin tritum, meaning "threshed." The genus Triticum encompasses a diverse group of wheat species, each with unique genetic characteristics.

1.2 Structural Anatomy of the Wheat Kernel

Foods are considered to be whole grains if all components of the kernel — the bran, germ, and endosperm — are present in their natural proportions. Both the fiber-rich bran outer coating and the inner germ are rich in micronutrients and phytochemicals, whereas the endosperm middle layer mainly consists of starch. In the refining process, components of the grain that are part of the bran and germ are lost, including fiber, minerals, vitamins, lignans, and other phytochemicals.

1.3 Common Forms and Preparations

Wheat is processed, consumed, and used as a dietary supplement in several distinct forms:

• Whole grain wheat flour and bread: Wheat is used in producing bread, pastries, and household flour, and also serves as food for livestock, among other uses.
• Wheat bran: The fibrous outer layer, separated during milling, rich in arabinoxylan, cellulose, and β-glucan. Used as a standalone supplement and as a food ingredient.
• Wheat germ: Wheat germ is the nutrient-dense embryo of the wheat kernel, responsible for the sprouting of a new plant. Wheat germ is a rich source of vitamin E, minerals, polyunsaturated fatty acids (PUFA), and fiber, and contains important phytochemicals such as flavonoids, octacosanols, and glutathione.
• Wheat germ oil (WGO): Wheat germ oil is rich in α-tocopherol (vitamin E), a vitamin long suggested to exert hepatoprotective effects.
• Fermented wheat germ extract (FWGE): The patented production process of FWGE consists of the extraction of wheat germs, fermentation by Saccharomyces cerevisiae, separation of the fermentation liquid, drying, and granulation. Wheat germ extracts are available over the counter as tablets, capsules, and drink powders.
• Wheatgrass (young wheat shoots): Wheatgrass juice is extracted from small wheat sprouts obtained after 6–10 days of germination. People can consume wheatgrass fresh or in various other ways, such as fresh or frozen juice, tablets, and powder.

2. Traditional and Historical Use

2.1 Origins and Prehistoric Cultivation

Archaeological evidence indicates that wheat has been a staple in human diets since its domestication in the Fertile Crescent around 9,000 BC. The first cereal grains were domesticated about 12,000 years ago by ancient farming communities in the Fertile Crescent region. Emmer wheat, einkorn wheat, and barley were three of the so-called Neolithic founder crops in the development of agriculture.

Archaeological evidence suggests that early humans first began cultivating wild wheat species such as einkorn and emmer. These ancient varieties were the ancestors of modern wheat and marked the transition from hunter-gatherer societies to agricultural ones. Excavations at sites like Çatalhöyük in Turkey have unearthed carbonized wheat grains, providing tangible evidence of early wheat cultivation.

2.2 Spread Across Ancient Civilizations

Over time, selective breeding led to the domestication of wheat species such as einkorn, emmer, and spelt. With the rise of agriculture, wheat cultivation spread across ancient civilizations, including Mesopotamia, Egypt, and the Indus Valley.

Around 3,500 BCE, Sumerians in Mesopotamia developed irrigation systems specifically designed for wheat cultivation, enabling reliable wheat harvests in arid regions and supporting the growth of the world's first urban civilizations. Cuneiform tablets from Uruk document wheat storage, distribution, and taxation, showing wheat's role in early state administration and economic systems in ancient Mesopotamia.

Wheat, particularly emmer wheat, was a staple food in ancient Egypt and was used to make bread and beer, two essential components of the Egyptian diet. The ancient Egyptians were not the first to cultivate wheat, but wheat was certainly one of their staple foods, and they were the first to discover how to make yeast-leavened bread. They fermented flour mixtures by using wild yeasts present in the air.

In ancient Greece and Rome, wheat continued to play a central role in the diet, particularly in the form of bread, which was a staple food for the common people.

In ancient Eurasian agriculture, the "new" glume wheat (Triticum timopheevii) was a notable crop, present across western Asia and Europe during the Neolithic and Bronze Ages, and played a role in the cultural practices of these regions.

The processing of cereals at Göbekli Tepe, a site known for its monumental architecture and ritual significance, suggests that wheat was not only a staple food but also integral to the social and ceremonial activities of its builders.

2.3 Medieval and Pre-Modern Use

Wheat remained a staple crop throughout the medieval period in Europe, where feudal lords controlled vast wheat fields worked by serfs. The introduction of the horse collar and the use of watermills for grinding flour further boosted wheat production, supporting the growing populations of towns and cities.

Because wheat is the only grain with sufficient gluten content to make leavened bread, wheat quickly became favored over other grains grown at the time, such as oats, millet, rice, and barley.

2.4 Traditional Medicinal Uses

Common wheat (Triticum aestivum) is known not only for its uses in baking and cooking but also for its medicinal uses; its medical benefits are enormous and scattered across different traditions and periods. The study of ancient wheat varieties and their nutritional properties continues to offer valuable information on the evolution of human diets and the potential health benefits of these grains. Wheat bran was historically used as a bulking laxative, and wheat poultices were applied externally in folk medicine traditions across the Mediterranean and Middle East.

3. Key Constituents and Active Compounds

3.1 Dietary Fiber Fractions

Whole grain wheat contains fermentable and non-fermentable fibers, including hemicellulose, arabinoxylan, and β-glucan, lignin, and oligosaccharides. Among wheat bran non-starch polysaccharides (NSP), arabinoxylan is the most represented at 70%, with cellulose accounting for 19%, and β-glucans for 6%.

These fiber classes exert distinct physiological mechanisms:

• Non-viscous and non-fermentable dietary fiber (such as wheat bran) plays a role in promoting gut motility largely through its bulking characteristics. Viscous dietary fiber (mostly soluble dietary fiber) is related to cardiovascular and glycemic benefits through its effect on the rheological properties of the digesta, which decreases the rate of digestion and absorption of macronutrients.
• Fermentable dietary fiber acts as a prebiotic, providing a carbon source for the growth of beneficial microbiota in the colon. Fermentation of these dietary fibers results in specific changes in the composition and/or activity of gut microbiota, which supports host health.

3.2 Phenolic Acids and Polyphenols

Wheat is a good source of dietary fiber, resistant starch, phenolic acids, alkylresorcinols, lignans, and diverse antioxidant compounds such as carotenoids, tocopherols, and tocotrienols. Different biological activities of wheat have been correlated with the presence of polyphenols due to their antioxidant activities and other preventative capabilities.

3.3 Proteins: Gluten, Gliadin, Amylase-Trypsin Inhibitors (ATIs)

Wheat is distinguished among cereal grains by its high content of storage proteins collectively termed gluten (comprising the gliadin and glutenin fractions). It is important to consider that wheat, in addition to gliadin, contains a number of other potentially bioactive components, including amylase trypsin inhibitors (ATIs) and fermentable oligo-disaccharides-monosaccharides and polyols (FODMAPs), which may cause gastrointestinal symptoms in susceptible individuals.

3.4 Wheat Germ Constituents

Unlike most cereals that are deficient in lysine and have minimal tryptophan content, wheat germ is a good source of these amino acids and many other essential amino acids. Fermented wheat germ extract (FWGE) is a multisubstance composition that, among other compounds, contains 2-methoxy benzoquinone and 2,6-dimethoxy benzoquinone, which are likely to exert some of its biological effects. FWGE interferes with anaerobic glycolysis, pentose cycle, and ribonucleotide reductase.

3.5 Wheat Germ Oil Constituents

Due to its particularly high policosanol contents (especially octacosanol), wheat germ oil has been studied for potential roles in cholesterol management, chronic inflammatory reactions, and neurological disorders. Wheat germ oil contains linoleic (n-6) acid approximately 55%, palmitic acid 16%, oleic acid 14%, and linolenic acid (n-3) approximately 7%.

3.6 Wheatgrass Constituents

The components of wheatgrass include chlorophyll, flavonoids, 17 amino acids (8 of which are essential), vitamins A, C, and E, and high mineral content (iron, calcium, magnesium, zinc). Numerous bioactive substances are contained in wheatgrass (Triticum aestivum), including minerals, amino acids, and vitamins A, B, C, E, and K.

4. Mechanisms of Action

4.1 Arabinoxylan and Blood Glucose Regulation

Research indicates that the antiglycemic effect of arabinoxylans may be derived from inhibiting intestinal α-glucosidase activity, but not amylase activity. It is purported that soluble fibers increase lumen viscosity, thereby delaying nutrient absorption. The effect of arabinoxylans on blood glucose is dose-dependent.

4.2 β-Glucan and Lipid/Glycemic Mechanisms

Health effects of β-glucan validated by clinical trials include reduction of blood total and LDL-cholesterol, glycemia, satiety, improving insulin sensitivity, and increasing short-chain fatty acid (SCFA) production. β-Glucan, arabinoxylan, and associated polyphenols appear to have synergistic effects on biological parameters.

4.3 Fermented Wheat Germ Extract (FWGE) Anticancer Mechanisms

FWGE interferes with anaerobic glycolysis, the pentose cycle, and ribonucleotide reductase. It has significant antiproliferative effects and kills tumor cells by the induction of apoptosis via the caspase–poly[ADP-ribose] polymerase pathway. FWGE interacts synergistically with a variety of different anticancer drugs and has demonstrated antimetastatic properties in mouse models. In addition, FWGE modulates immune response by downregulation of MHC-I complex and the induction of TNF-α and various interleukins.

4.4 Prebiotic and Gut Microbiome Effects

Prebiotic activities of cereal grain polysaccharides have been thoroughly tested. In vitro fermentation studies have shown the possibility of synergistic activities between arabinoxylan (AX) and β-glucan promoting the increase in the total number of bacteria, as well as beneficial groups of Bifidobacterium.

5. Scientific Evidence by Area of Health

5.1 Cardiovascular Health

Epidemiological Evidence (Strong, Consistent):

There is a consistent, inverse association between dietary whole grains and incident cardiovascular disease in epidemiological cohort studies. A key meta-analysis pooling seven prospective cohort studies found that greater whole grain intake (pooled average 2.5 servings/day vs. 0.2 servings/day) was associated with a 21% lower risk of CVD events (OR 0.79, 95% CI: 0.73–0.85).

A large 2016 systematic review and dose-response meta-analysis of prospective studies concluded that whole grain intake is associated with a reduced risk of coronary heart disease, cardiovascular disease, and total cancer, and mortality from all causes, respiratory diseases, infectious diseases, diabetes, and all non-cardiovascular, non-cancer causes. Reductions in risk were observed up to an intake of 210–225 g/day (seven to seven-and-a-half servings per day) for most outcomes.

Intervention Trial Evidence (Moderate):

A randomized controlled dietary trial in middle-aged healthy individuals found that consumption of 3 daily portions of whole-grain foods (provided as only wheat or a mixture of wheat and oats) was assessed in relatively high-risk individuals. After a 4-week run-in period with a refined diet, volunteers were randomly allocated to a control, wheat, or wheat+oats group for 12 weeks. Daily consumption of 3 portions of whole-grain foods was found to significantly reduce cardiovascular disease risk in middle-aged people, mainly through blood pressure-lowering mechanisms. The observed decrease in systolic blood pressure could decrease the incidence of coronary artery disease and stroke by ≥15% and 25%, respectively.

Multiple observational studies have replicated this association, and important causal pathways have been elucidated, including effects on glucose homeostasis, serum lipids, and endothelial function.

Limitation: The majority of favorable evidence derives from observational (cohort) studies, which are susceptible to dietary confounding. Controlled clinical trials specifically isolating whole wheat (as opposed to mixed whole-grain interventions) are fewer in number and often shorter in duration.

5.2 Type 2 Diabetes

Evidence Strength: Moderate to Strong (Epidemiological); Preliminary (Mechanistic/Intervention)

A 2024 burden-of-proof analysis drawing on 27 prospective cohorts found that consuming whole grain at the range of the theoretical minimum risk exposure level (118.5–148.1 g per day) was associated with a lower risk of type 2 diabetes (declined by 37.3%, 95% UI: 5.8 to 59.5).

Several prospective studies have shown a 20%–30% reduced risk of type 2 diabetes with greater intake of whole grains or cereal fiber, though data regarding the association of whole grain intake with type 2 diabetes are not entirely homogeneous. For arabinoxylan specifically, arabinoxylan consumption at 15 g/day over 6 weeks significantly lowered the postprandial responses of serum glucose and insulin to a liquid meal challenge test in overweight subjects with impaired glucose tolerance.

A human study using bread enriched with arabinoxylan at doses of 0, 6, and 12 g found that a significant reduction in blood glucose and peak plasma glucose were observed. However, results in this area are not uniformly positive. Bread enriched with certain types of dietary fiber did not show suitable potential to reduce glycemic response when subjects with type 2 diabetes consumed foods with high addition of ground ultrafine wheat bran (19 g/day). Similarly, consumption of whole-grain products with 112 g fiber/day for six weeks made with ground whole wheat did not alter insulin sensitivity, fasting blood glucose, or markers of lipid peroxidation and inflammation in overweight individuals.

5.3 Colorectal Cancer Risk

Evidence Strength: Moderate (Epidemiological)

A high intake of whole grains has previously been associated with reduced risk of colorectal cancer, type 2 diabetes, and overweight or obesity. The 2024 burden-of-proof analysis found that consuming whole grain at the TMREL range was associated with a reduction in colorectal cancer risk of approximately 17.3% (95% UI: 6.5 to 27.7).

Intakes of specific types of whole grains including whole grain bread, whole grain breakfast cereals, and added bran, as well as total bread and total breakfast cereals, were associated with reduced risks of cardiovascular disease and/or all-cause mortality, but there was little evidence of an association with refined grains.

Limitation: Most evidence in this domain remains observational. The heterogeneity of "whole grain" definitions across studies complicates dose-response estimates. Previous studies on whole grain consumption had inconsistent findings and lacked quantitative assessments of evidence quality.

5.4 Gut Health and Digestive Function

Evidence Strength: Moderate (Mechanistic and Clinical)

Dietary fiber is known to increase fecal bulk. Insoluble wheat bran fiber, by virtue of its bulking properties, has a well-documented laxative effect. These constituents provide Triticum aestivum with a range of pharmacological properties, including laxative effects. Prebiotic fermentation of wheat arabinoxylan in the colon promotes growth of beneficial bacteria.

5.5 Wheatgrass: Adjunct in Oncology and Hematology

Evidence Strength: Preliminary; Very Limited Clinical Data

Laboratory in vitro studies, mostly using fermented wheat germ extract, have demonstrated anticancer potential; antiproliferative effects were observed in different cancer cell lines. Further in vitro studies have identified apoptosis as a possible mechanism. In animal experiments, wheatgrass demonstrated benefits in cancer prevention and as an adjunct to cancer treatment, as well as benefits to immunological activity and oxidative stress. Clinical trials show that wheatgrass may induce synergistic benefits to chemotherapy and may attenuate chemotherapy-related side effects.

One controlled prospective trial enrolled 100 stage II–III colorectal cancer patients, divided into control (chemotherapy alone) and intervention groups of 50 patients each, with the intervention group consuming 60 cc wheatgrass juice daily. Anti-inflammatory cytokine IL-10 concentrations were significantly higher in the wheatgrass juice group than in the control group at treatment termination, and the decline in white blood cell counts between baseline and treatment end was significantly lower in the wheatgrass juice group. However, no significant differences were observed in IL-6, IL-8, and IL-12 concentrations between the study groups.

An earlier pilot study in breast cancer patients found that wheatgrass juice, in addition to chemotherapy, showed myelotoxicity reduction potential and decreased the dose and requirement for granulocyte colony-stimulating factor.

In a study on thalassemia, wheatgrass tablets were given to 40 children (aged 2 to over 8 years) suffering from thalassemia major on an empty stomach for at least one year in divided doses of two to eight tablets per day (500 mg per tablet). This treatment was reported to improve hemoglobin levels, increase the intervals required between consecutive blood transfusions, and decrease the amount of blood required for transfusion.

Overall limitation: There is a dearth of scientific evidence to back up wheatgrass's possible pharmacological effects and clinical value. The available human trials are small, often non-randomized or non-blinded, and further large-scale controlled trials are needed.

5.6 Fermented Wheat Germ Extract (FWGE) and Cancer

Evidence Strength: Preliminary (Small Clinical Trials)

In a large in vitro anticancer drug screen, FWGE was found to possess potential antitumor activity in colon, testis, thyroid, ovary, non-small-cell lung cancer (NSCLC), breast, gastric, head and neck, hepatoma, glioblastoma, melanoma, cervix, and neuroblastoma human cancer cell lines. Wheat germ extract is used as a dietary supplement to improve quality of life in certain cancers. Lab and animal studies indicate wheat germ extract may have anticancer, antimetastatic, and immunomodulatory effects. However, clinical evidence from large, well-controlled randomized trials remains limited, and most positive findings are based on in vitro or early-phase studies.

5.7 Antioxidant Activity

Wheatgrass possesses many beneficial antioxidant properties, including anti-cancer activity, anti-bacterial activity, anti-fungal activity, and anti-microbial activity. Different biological activities of wheat have been correlated with the presence of polyphenols due to their antioxidant activities and other preventative capabilities. These claims are predominantly supported by in vitro and animal data. Robust clinical trials measuring antioxidant endpoints in humans are limited.

5.8 Wheat Germ Oil: Vitamin E and Lipid Health

Wheat germ oil, which is a valuable source of essential fatty acids, may assist in muscular dystrophies and other neuromuscular disorders. Wheat germ oil is particularly high in octacosanol — a long-chain saturated primary alcohol found in a number of different vegetable waxes — which has been reported to lower plasma cholesterol in humans. Evidence for ergogenic (exercise performance-enhancing) effects of octacosanol from wheat germ oil is mixed; animal studies have not consistently shown benefit, and human data remain limited.

6. Body Systems and Health Areas Associated with Wheat

• Cardiovascular system: Whole grain intake is consistently associated with reduced CVD risk in epidemiological studies, mediated through effects on blood pressure, serum lipids, and endothelial function.
• Gastrointestinal and digestive system: Wheat bran fiber promotes bowel regularity and increases fecal bulk; arabinoxylan acts as a prebiotic substrate.
• Metabolic and endocrine system: Arabinoxylan and whole grain fiber contribute to glycemic control and reduced type 2 diabetes risk.
• Immune and hematological system: Wheatgrass juice has been studied for its effects on white blood cell preservation during chemotherapy and on immune cytokine profiles.
• Oncological applications: Fermented wheat germ extract and wheatgrass juice have been investigated as adjuncts to conventional cancer treatments, primarily in vitro and in early-phase clinical settings.
• Skin and integument: Wheat germ oil is readily absorbed by human skin, making it an effective moisturizer. When applied to the skin, it delivers vitamin A, vitamin D, B vitamins, antioxidants, and fatty acids.
• Musculoskeletal and neuromuscular system: Wheat germ oil may assist muscular dystrophies and other neuromuscular disorders.

7. Dosage Forms and Dosages Reported in Studies

The following dosages appear in peer-reviewed clinical literature. These are reported as used in research, not as prescriptive recommendations.

• Whole grain wheat (CVD/metabolic intervention): Three daily portions of whole-grain foods (provided as only wheat or a mixture of wheat and oats) were tested over a 12-week randomized controlled trial in middle-aged individuals. Reductions in risk were observed up to an intake of 210–225 g/day (seven to seven-and-a-half servings per day).
• Arabinoxylan (glycemic trials): Arabinoxylan was extracted from wheat bran and used in bread at 0, 6, and 12 g doses; a significant reduction in blood glucose and peak plasma glucose were observed. Arabinoxylan at 15 g/day over 6 weeks significantly lowered postprandial glucose and insulin responses in overweight subjects with impaired glucose tolerance.
• Wheatgrass juice (oncology trials): In a controlled prospective trial, patients in the intervention group consumed 60 cc of wheatgrass juice daily alongside standard chemotherapy.
• Wheatgrass tablets (thalassemia): Wheatgrass tablets were administered on an empty stomach for at least one year in divided doses of two to eight tablets per day (500 mg per tablet).
• Wheatgrass forms: Forms of wheatgrass include fresh juice, frozen juice, tablets, and powders, with compositions varying according to their production processes, as well as the growing conditions of the wheatgrass.
• Whole grain intake (TMREL estimate): Consuming whole grain at the range of the theoretical minimum risk exposure level (118.5–148.1 g per day) was associated with lower risks of type 2 diabetes, colorectal cancer, stroke, and ischemic heart disease in a burden-of-proof meta-analysis of 27 prospective cohorts.

8. Safety Considerations and Interactions

8.1 Celiac Disease

Celiac disease (CD) is an autoimmune disease occurring in genetically susceptible individuals with HLA-DQ2 and/or HLA-DQ8 genotypes. CD is characterized by the presence of specific serological antibodies such as anti-tissue transglutaminase (tTG) IgA, anti-endomysium IgA (EMA), and anti-deamidated gliadin peptides IgG (DPG). In celiac disease, gluten triggers an immune reaction leading to enteropathy, malabsorption, and symptoms. A strict, lifelong gluten-free diet is the only established treatment for celiac disease.

8.2 Non-Celiac Gluten/Wheat Sensitivity (NCGS/NCWS)

The terms non-celiac gluten sensitivity (NCGS) and non-celiac wheat sensitivity (NCWS) are generally used to refer to a condition where removing gluten from the diet resolves symptoms, after testing negative for celiac disease and a wheat allergy. In NCGS/NCWS, gluten intake does not cause enteropathy or malabsorption, but different gastrointestinal and extraintestinal symptoms — such as abdominal pain, diarrhea, constipation, bloating, headaches, and brain fog — are triggered by wheat or gluten intake.

Previous studies have shown symptoms to be induced by gluten, while others have indicated that different components of wheat, such as fructans or amylase trypsin inhibitors (ATIs), can trigger symptoms in NCGS/NCWS. Due to the lack of sensitive and reproducible biomarkers for NCGS diagnosis, placebo-controlled gluten challenges must be carried out for its diagnosis. There is a great deal of skepticism within the scientific community questioning the existence of NCGS as a distinct clinical disorder.

8.3 Wheat Allergy

Wheat allergy is characterized by the production of IgE antibodies against wheat proteins and the development of symptoms of immediate-type food allergy. Wheat allergy — classified as a classic food allergy — is induced by wheat (not only gluten) intake and leads to type I and type IV hypersensitivity.

8.4 Gluten in Wheatgrass

People with celiac disease and those who are sensitive to gluten can still enjoy wheatgrass because only the wheat kernel and not wheatgrass contains gluten. However, cross-contamination during harvesting or processing is a practical concern that individuals with celiac disease should consider.

8.5 General Safety of Wheatgrass

Most studies report no significant adverse effects after consuming wheatgrass, but this may depend on the form of the product and the individual. Some people may have a sensitivity or allergy that leads to an unwanted reaction.

8.6 Evidence Gaps and Research Limitations

More clinical trials, in vivo and in vitro studies are warranted to broaden the knowledge about the effect of Triticum aestivum on nutrition-related disease prevention and physical and mental well-being sustenance. Reviews have also pointed out the lack of research using wheat bran or purified wheat bran fiber components in randomized, controlled clinical trials. Much of the available mechanistic data on wheat phytochemicals — including alkylresorcinols, phenolic acids, and fermented germ extract bioactive quinones — derives from in vitro cell studies and animal models, limiting direct extrapolation to human health outcomes.

References

• Abubakar AR, et al. "General Health Benefits and Pharmacological Activities of Triticum aestivum L." Molecules. 2022. PMC8953994.
• Exploration Publishing. "Nutritional prospects of wheatgrass (Triticum aestivum) and its effects in treatment and chemoprevention." 2022.
• Abubakar AR, et al. "General Health Benefits and Pharmacological Activities of Triticum aestivum L." Molecules. 2022;27(6):1948.
• ScienceDirect. "Triticum aestivum — an overview." ScienceDirect Topics.
• Springer Nature. "Structural, functional, nutritional composition and analytical profiling of Triticum aestivum L." Applied Biological Chemistry. 2023.
• Mellen PB, et al. "Whole grain intake and cardiovascular disease: a meta-analysis." Nutrition, Metabolism and Cardiovascular Diseases. 2007. PubMed PMID: 17449231.
• Tighe P, et al. "Effect of increased consumption of whole-grain foods on blood pressure and other cardiovascular risk markers in healthy middle-aged persons: a randomized controlled trial." American Journal of Clinical Nutrition. 2010. PubMed PMID: 20685951.
• Aune D, et al. "Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose-response meta-analysis of prospective studies." BMJ. 2016. PMC4908315.
• Mendis MMM, et al. "Antiglycemic Effect of Water Extractable Arabinoxylan from Wheat Aleurone and Bran." PMC5463155.
• Brouns F, et al. "Functional and Nutritional Characteristics of Natural or Modified Wheat Bran Non-Starch Polysaccharides: A Literature Review." PMC10379113.
• Losurdo G, et al. "Non-celiac gluten sensitivity and diagnostic challenges." PMC6040028.
• Volta U, et al. "Non-Celiac Gluten Sensitivity: An Update." PMC8224613.
• Ierardi E, et al. "Non-celiac wheat sensitivity: rationality and irrationality of a gluten-free diet in individuals affected with non-celiac disease." PMC7788993.
• Abdi F, et al. "Nutritional Considerations in Celiac Disease and Non-Celiac Gluten/Wheat Sensitivity." Nutrients. 2023. PMC10058476.
• Avisar A, et al. "Wheatgrass Juice Administration and Immune Measures during Adjuvant Chemotherapy in Colon Cancer Patients: Preliminary Results." Pharmaceuticals. 2020. PMC7345549.
• Bar-Sela G, et al. "Extracellular Vesicles Reflect the Efficacy of Wheatgrass Juice Supplement in Colon Cancer Patients During Adjuvant Chemotherapy." PMC7479215.
• "The Role of Wheatgrass in Colorectal Cancer: A Review of the Current Evidence." PMC11121291.
• Mueller T, Voigt W. "Fermented wheat germ extract — nutritional supplement or anticancer drug?" Nutrition Journal. 2011. PMC3179707.
• Sharma P, et al. "Studies on the nutraceuticals composition of wheat derived oils wheat bran oil and wheat germ oil." PMC4325061.
• Bartolini D, et al. "Wheat germ oil vitamin E cytoprotective effect and its nutrigenomics signature in human hepatocyte lipotoxicity." PMC9525900.
• Lu Y, et al. "Estimating effects of whole grain consumption on type 2 diabetes, colorectal cancer and cardiovascular disease: a burden of proof study." Nutrition Journal. 2024. PMC11092208.
• de Munter JSL, et al. "Whole Grain, Bran, and Germ Intake and Risk of Type 2 Diabetes: A Prospective Cohort Study and Systematic Review." PMC1952203.
• Panchal SK, et al. "Phenolic Biotransformations in Wheatgrass Juice after Primary and Secondary Fermentation." PMC10138189.
• Nyu. "The Archaeological Record of Wheat: From Neolithic Innovations to Modern Developments." Triticeae Genomics and Genetics. 2024.
• Shewry PR, Hey SJ. "Re-discovering ancient wheat varieties as functional foods." Journal of Cereal Science. 2015.
• Gebruers K, et al. "Genetic Approaches to Increase Arabinoxylan and β-Glucan Content in Wheat." Plants. 2023.
• ScienceDirect. "Wheat Germ Oil — an overview." ScienceDirect Topics.